Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers again raises outlook for fiscal year 2021 after strong third quarter
Press release

Siemens Healthineers again raises outlook for fiscal year 2021 after strong third quarter

Published on July 30, 2021

Q3 Fiscal Year 2021

  • Very good revenue development across the board in the third quarter – comparable growth of 38.9% from prior-year quarter, which was considerably challenged by the COVID-19 pandemic
  • Equipment book-to-bill ratio at a very good 1.18
  • Revenue from rapid COVID-19 antigen tests reaches peak in the third quarter – Diagnostics revenue doubled year-over-year, with a comparable growth of 103.4%
  • Comparable revenue growth of 17.0% in Imaging; Advanced Therapies with a comparable growth of 11.8%
  • Varian acquisition successfully completed on April 15, 2021 – excellent start of Varian within Siemens Healthineers with an equipment book-to-bill ratio of 1.37 and a solid revenue contribution
  • Adjusted EBIT doubled to €945 million – strong margin of 18.8%
  • Adjusted basic earnings per share up 84% to €0.56 from €0.31 in the prior-year quarter
  • Free cash flow by far more than doubled year-over-year to €852 million

Updated Outlook for Fiscal Year 2021

  • Comparable revenue growth between 17% and 19% expected (previously 14% to 17%)
  • Adjusted basic earnings per share between €1.95 and €2.05 (previously €1.90 to €2.05) 

Bernd Montag, CEO of Siemens Healthineers AG:
»The Siemens Healthineers team, strengthened by our new colleagues from Varian since April, again delivered an excellent performance in the third quarter. With significant growth in revenue, earnings and cash flow, the strong business momentum from the previous quarters continued. Now, as an even stronger team we are an even more attractive partner for our customers and are overall increasing our relevance for healthcare systems globally. Based on the overall excellent development in the first nine months, we are again raising the outlook for fiscal year 2021.«

Download quarterly statement(pdf, 355.52 KB)

Siemens Healthineers 2021

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Following the acquisition of Varian Medical Systems, Inc. the company has approximately 66,000 employees worldwide. Further information is available at www.siemens-healthineers.com.